Lexicon Pharmaceuticals share price logo

Lexicon Pharmaceuticals

NASDAQ: LXRX

Small Cap

$2.24

-0.02

(-0.88%)

as on

Lexicon Pharmaceuticals Stock Performance

as on September 5, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $2.21
    $2.25
    downward going graph

    1.34%

    Downside

    0.45%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.03
    $2.68
    downward going graph

    54.02%

    Downside

    19.64%

    Upside

    downward going graph

Lexicon Pharmaceuticals share price movements today

Previous Close
$2.26
Open
$2.25
Volume
945.2K
Market Cap
$996.7M
Day's Low - High
$2.21 - $2.25
52 Week Low - High
$1.03 - $2.68

Lexicon Pharmaceuticals Historical Returns

1 Month Return
-9.24 %
3 Month Return
+ 18.95 %
1 Year Return
+ 111.21 %
3 Year Return
+ 33.73 %
5 Year Return
-54.53 %

Lexicon Pharmaceuticals Stock Fundamentals & Key Indicators

Check Lexicon Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$996.7M

EPS (TTM)

-0.1663

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.63%

PE Ratio (TTM)

0

PEG Ratio

-0.14

EBITDA

-54.0M

Revenue (TTM)

41.5M

Profit Margin

-147.38%

Return On Equity TTM

-40.21%

Lexicon Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lexicon Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$996.7M-54.53%NA-147.38%NA
BUY$44.6B614.61%NA0.00%NA
BUY$141.1B181.73%32.2186.04%NA
BUY$60.2B-64.27%-18.66-12.57%NA
BUY$84.8B24.12%20.1484.86%0.44%

Stock Returns calculator for Lexicon Pharmaceuticals Stock including INR - Dollar returns

The Lexicon Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Lexicon Pharmaceuticals investment value today

Current value as on today

₹2,24,281

Returns

₹1,24,281

(+124.28%)

Returns from Lexicon Pharmaceuticals Stock

₹1,09,346 (+109.35%)

Dollar Impact

₹14,935 (+14.94%)

Analyst Recommendation on Lexicon Pharmaceuticals Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Lexicon Pharmaceuticals. Average target price of $3.86

Lexicon Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Lexicon Pharmaceuticals.

What analysts predicted

41.97%UPSIDE

Target Price

$3.86

Current Price

$2.24

Analyzed by

2 Analysts

Target

$3.86

Lexicon Pharmaceuticals target price $3.86, a slight upside of 41.97% compared to current price of $2.24. According to 2 analysts rating.

Indian Investors' Interest in Lexicon Pharmaceuticals Stock

Search interest for Lexicon Pharmaceuticals Stock has increased by 236% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:236% versus previous 30 day period

Lexicon Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1
1
1
26
1
28
14
5
21
0
Gross Profit
0
1
1
0
1
28
14
5
20
0
Operating Income
-45
-55
-63
-32
-25
3
-12
-14
0
-26
EBITDA
-44
-51
-60
-20
-23
5
-10
-13
0
-29
Interest Expense
4
2
4
3
1
2
2
2
1
2
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-48
-53
-64
-33
-25
3
-12
-15
-1
-31
Income Tax Expense
0
-
-
0
-
-
-
-
-
-
Net Income
-48
-53
-64
-33
-25
3
-12
-15
-1
-31
Net Profit Margin
-4282.92%
-3244.02%
-3703.49%
-127.16%
-2004.36%
11.27%
-90.04%
-282.72%
-4.94%
-4591.76%

Lexicon Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
83
90
63
322
23
0
0
1
31
49
Gross Profit
-80
88
60
318
22
-54
-52
-57
30
49
Operating Income
-137
-136
-103
141
-47
-87
-100
-171
-197
-48
EBITDA
-125
-125
-96
148
-41
-86
-100
-169
-184
-41
Interest Expense
6
6
20
20
14
0
2
13
15
8
Depreciation
-
3
3
3
2
0
0
0
0
0
Income Before Tax
-141
-141
-120
124
-58
-87
-101
-177
-200
-50
Income Tax Expense
4
-12
3
-6
11
0
1
0
-200
-
Net Income
-141
-129
-120
130
-58
-87
-101
-177
-200
-50
Net Profit Margin
-169.71%
-142.86%
-190.71%
40.40%
-244.11%
-29448.99%
-73341.01%
-14710.88%
-644.78%
-101.08%

Lexicon Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-53
-64
-33
-25
3
-12
-15
-1
-32
Operating Cash Flow
-48
-53
-21
-43
16
-23
-17
-14
-23
Investing Cash Flow
-12
53
53
40
15
52
4
-70
-86
Financing Cash Flow
0
0
0
0
-45
-
-2
88
88
Change in Cash
-60
-1
32
-3
-12
28
-15
3
-22

Lexicon Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-129
-120
130
-58
-87
-101
-177
-200
-50
Operating Cash Flow
-185
-148
113
-142
-87
-88
-161
-178
-67
Investing Cash Flow
50
169
-155
380
2
-71
-49
-15
113
Financing Cash Flow
149
-2
-2
-147
22
142
187
238
-48
Change in Cash
15
18
-44
90
-62
-17
-23
44
-3

Mutual Funds that own Lexicon Pharmaceuticals Stock

Check out the Mutual Funds with significant holdings in Lexicon Pharmaceuticals.

Funds
Holdings
Shares Held
Fidelity Mt. Vernon Street Trust
4.962702%
22081841
VANGUARD INDEX FUNDS
2.088954%
9294928
Fidelity Concord Street Trust
0.42093%
1872957
VANGUARD WORLD FUND
0.123337%
548799
Fidelity Select Portfolios
0.115809%
515300

Global Institutional Holdings in Lexicon Pharmaceuticals

Funds
Holdings
Vanguard
2.81%
iShares
2.12%
SPDR
0.57%
Schwab
0.27%
Invesco
0.09%

Insights on Lexicon Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, LXRX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, LXRX stock has moved up by 105.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 479.0% return, outperforming this stock by 373.5%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 21.10M → 692.0K (in $), with an average decrease of 96.7% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -1.04M → -31.77M (in $), with an average decrease of 2946.5% per quarter

About Lexicon Pharmaceuticals

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes. It also commercializes INPEFA (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, CKD, and other cardiovascular risk factors. In addition, the company develops LX9851, an orally-delivered small molecule drug candidate for the treatment of obesity and associated cardiometabolic disorders, and pilavapadin (LX9211), an orally-delivered small molecule drug candidate for the treatment of neuropathic pain. It has strategic collaboration and license agreements with Viatris Inc. and Bristol-Myers Squibb Company. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.
OrganisationLexicon Pharmaceuticals
Headquarters2445 Technology Forest Boulevard, The Woodlands, TX, United States, 77381
IndustryBiotechnology
CEODr. Michael S. Exton Ph.D.
E-voting on sharesClick here to vote

Key Management of Lexicon Pharmaceuticals

Name

Title

Ms. Rachel Yap Martens

Senior VP of Partnerships & Corporate Strategy

Mr. Brian T. Crum

Senior VP, General Counsel & Secretary

Dr. Craig B. Granowitz M.D., Ph.D.

Senior VP & Chief Medical Officer

Ms. Lisa M. DeFrancesco

Senior Vice President of Investor Relations & Corporate Communications

Ms. Kristen L. Alexander

Vice President of Finance & Accounting

Dr. Suma Gopinathan M.S., Ph.D.

Senior Vice President of Discovery

Dr. Michael S. Exton Ph.D.

CEO & Director

Mr. Scott M. Coiante

Senior VP & CFO

Ms. Wendy E. McDermott

Senior Vice President of Human Resources

FAQs

What is Lexicon Pharmaceuticals share price today?

Lexicon Pharmaceuticals share price today is $2.24 as on at the close of the market. Lexicon Pharmaceuticals share today touched a day high of $2.25 and a low of $2.21.

What is the 52 week high and 52 week low for Lexicon Pharmaceuticals share?

Lexicon Pharmaceuticals share touched a 52 week high of $2.68 on and a 52 week low of $1.03 on . Lexicon Pharmaceuticals stock price today i.e. is closed at $2.24,which is 16.42% down from its 52 week high and 117.48% up from its 52 week low.

What is Lexicon Pharmaceuticals's market capitalisation today?

Lexicon Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Lexicon Pharmaceuticals Stock (LXRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lexicon Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lexicon Pharmaceuticals Shares that will get you 0.6696 shares as per Lexicon Pharmaceuticals share price of $2.24 per share as on September 5, 2026 at 8:45 am IST.

What is the minimum amount required to buy Lexicon Pharmaceuticals Stock (LXRX) from India?

Indian investors can start investing in Lexicon Pharmaceuticals (LXRX) shares with as little as ₹94.485 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.85 in Lexicon Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Lexicon Pharmaceuticals share’s latest price of $2.24 as on September 5, 2026 at 8:45 am IST, you will get 4.4643 shares of Lexicon Pharmaceuticals. Learn more about fractional shares .

What are the returns that Lexicon Pharmaceuticals has given to Indian investors in the last 5 years?

Lexicon Pharmaceuticals stock has given -54.53% share price returns and 29.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?